Zoulim F - Search Results

1

A global scientific strategy to cure hepatitis B.

Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, Hu J, Kramvis A, Lampertico P, Janssen HLA, Levrero M, Li W, Liang TJ, Lim SG, Lu F, Penicaud MC, Tavis JE, Thimme R; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors; Zoulim F. Revill PA, et al. Among authors: zoulim f. Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558. doi: 10.1016/S2468-1253(19)30119-0. Epub 2019 Apr 10. Lancet Gastroenterol Hepatol. 2019. PMID: 30981686 Free PMC article.

2

Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.

Delmas J, Schorr O, Jamard C, Gibbs C, Trépo C, Hantz O, Zoulim F. Delmas J, et al. Among authors: zoulim f. Antimicrob Agents Chemother. 2002 Feb;46(2):425-33. doi: 10.1128/AAC.46.2.425-433.2002. Antimicrob Agents Chemother. 2002. PMID: 11796353 Free PMC article.

3

A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection.

Zoulim F. Zoulim F. Drug Saf. 2002;25(7):497-510. doi: 10.2165/00002018-200225070-00004. Drug Saf. 2002. PMID: 12093308 Review.

4

Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.

Le Guerhier F, Thermet A, Guerret S, Chevallier M, Jamard C, Gibbs CS, Trépo C, Cova L, Zoulim F. Le Guerhier F, et al. Among authors: zoulim f. J Hepatol. 2003 Mar;38(3):328-34. doi: 10.1016/s0168-8278(02)00425-7. J Hepatol. 2003. PMID: 12586299

5

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney WE 4th, Xiong S, Brosgart CL, Chen SS, Gibbs CS, Zoulim F. Werle-Lapostolle B, et al. Among authors: zoulim f. Gastroenterology. 2004 Jun;126(7):1750-8. doi: 10.1053/j.gastro.2004.03.018. Gastroenterology. 2004. PMID: 15188170

6

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus.

Durantel D, Carrouée-Durantel S, Werle-Lapostolle B, Brunelle MN, Pichoud C, Trépo C, Zoulim F. Durantel D, et al. Among authors: zoulim f. Hepatology. 2004 Oct;40(4):855-64. doi: 10.1002/hep.20388. Hepatology. 2004. PMID: 15382118

7

Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.

Zoulim F. Zoulim F. Antiviral Res. 2004 Oct;64(1):1-15. doi: 10.1016/j.antiviral.2004.07.003. Antiviral Res. 2004. PMID: 15451174 Review.

8

Management of antiviral resistance in patients with chronic hepatitis B.

Locarnini S, Hatzakis A, Heathcote J, Keeffe EB, Liang TJ, Mutimer D, Pawlotsky JM, Zoulim F. Locarnini S, et al. Among authors: zoulim f. Antivir Ther. 2004 Oct;9(5):679-93. Antivir Ther. 2004. PMID: 15535405 Review.

9

Antiviral therapy of chronic hepatitis B: can we clear the virus and prevent drug resistance?

Zoulim F. Zoulim F. Antivir Chem Chemother. 2004 Nov;15(6):299-305. doi: 10.1177/095632020401500602. Antivir Chem Chemother. 2004. PMID: 15646643 Free article. Review.

10

New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.

Zoulim F. Zoulim F. J Hepatol. 2005 Mar;42(3):302-8. doi: 10.1016/j.jhep.2004.12.015. J Hepatol. 2005. PMID: 15710212 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

619 results

Search Page